Fineline Cube

Follow:
14778 Articles
Merck Initiates Phase III MOVE-NOW Study for Lagevrio COVID-19 Antiviral
CompanyDrug

Merck Initiates Phase III MOVE-NOW Study for Lagevrio COVID-19 Antiviral

CDE Approves RinuaGene's mRNA-Based RG002 for Clinical Study in Cervical Dysplasia
CompanyDrug

CDE Approves RinuaGene’s mRNA-Based RG002 for Clinical Study in Cervical Dysplasia

Burning Rock Ltd Reports Q3 2024 Financials with Revenue Growth and R&D Reduction
Company

Burning Rock Ltd Reports Q3 2024 Financials with Revenue Growth and R&D Reduction

Novavax to Sell Czech Manufacturing Facility to Novo Nordisk for $200 Million
CompanyDeals

Novavax to Sell Czech Manufacturing Facility to Novo Nordisk for $200 Million

China's Health Commission Issues Guidelines to Strengthen Ties Between Healthcare and Elderly Care
HospitalPolicy / Regulatory

China’s Health Commission Issues Guidelines to Strengthen Ties Between Healthcare and Elderly Care

Eli Lilly's Zepbound Outperforms Wegovy in SURMOUNT-5 Weight Loss Study
CompanyDrug

Eli Lilly’s Zepbound Outperforms Wegovy in SURMOUNT-5 Weight Loss Study

Phanes Therapeutics' PT217 Earns FDA Fast Track Designation for Neuroendocrine Prostate Cancer
CompanyDrug

Phanes Therapeutics’ PT217 Earns FDA Fast Track Designation for Neuroendocrine Prostate Cancer

CGeneTech's Cetagliptin Receives NMPA Approval for Type 2 Diabetes Treatment in China
CompanyDrug

CGeneTech’s Cetagliptin Receives NMPA Approval for Type 2 Diabetes Treatment in China

Eisai and Biogen's Leqembi Approved in Mexico for Early Alzheimer's Disease Treatment
CompanyDrug

Eisai and Biogen’s Leqembi Approved in Mexico for Early Alzheimer’s Disease Treatment

AstraZeneca Appoints Iskra Reic as EVP, International, Amid Leon Wang's Investigation in China
Company

AstraZeneca Appoints Iskra Reic as EVP, International, Amid Leon Wang’s Investigation in China

Shanghai Escugen Receives NMPA Approval for Second Phase III Trial of ESG401 in TNBC
CompanyDrug

Shanghai Escugen Receives NMPA Approval for Second Phase III Trial of ESG401 in TNBC

Johnson & Johnson Submits sBLAs to FDA for Tremfya Indications in Pediatric Psoriasis and Arthritis
CompanyDrug

Johnson & Johnson Submits sBLAs to FDA for Tremfya Indications in Pediatric Psoriasis and Arthritis